Insider transaction feed
Latest SEC Form 4 insider trades with explainable signal scoring.
3,036 transactions Export CSV
Buy volume
$945.64M
1537 buy transactions
Sell volume
$2.12B
1499 sell transactions
Net flow
-$1.17B
Net selling
Total flow
$3.06B
3036 priced transactions
Net insider flow· last 30 days
Buys Sellsnet -$1.53B
Convergence— where independent disclosures line up
View all signals →
| Transaction | Flags | ||||||||
|---|---|---|---|---|---|---|---|---|---|
4d ago Jun 25, 2026 | INSMED Inc | Lewis William Chair and CEO · Director | Sell · S | 1,292 | $106.27 | $137.3K | Neutral+3 | 10b5-1 | |
4d ago Jun 25, 2026 | INSMED Inc | Lewis William Chair and CEO · Director | Sell · S | 2,456 | $105.27 | $258.5K | Neutral+3 | 10b5-1 | |
4d ago Jun 25, 2026 | INSMED Inc | Lewis William Chair and CEO · Director | Sell · S | 3,723 | $104.28 | $388.2K | Neutral+3 | 10b5-1 | |
4d ago Jun 25, 2026 | INSMED Inc | Lewis William Chair and CEO · Director | Sell · S | 1,836 | $103.10 | $189.3K | Neutral+3 | 10b5-1 | |
4d ago Jun 25, 2026 | INSMED Inc | Lewis William Chair and CEO · Director | Sell · S | 12,091 | $102.34 | $1.24M | Neutral+3 | 10b5-1 | |
4d ago Jun 25, 2026 | INSMED Inc | Lewis William Chair and CEO · Director | Buy · M | 8,880 | $17.16 | $152.4K | Neutral+3 | 10b5-1 | |
4d ago Jun 25, 2026 | INSMED Inc | Lewis William Chair and CEO · Director | Buy · M | 12,518 | $30.46 | $381.3K | Neutral+3 | 10b5-1 | |
4d ago Jun 24, 2026 | DICK'S SPORTING GOODS, INC. | STACK EDWARD W Executive Chairman · Director · 10% Owner | Buy · M | 958,466 | $0.00 | $0 | Neutral+8 | Deriv | |
4d ago Jun 24, 2026 | DICK'S SPORTING GOODS, INC. | STACK EDWARD W Executive Chairman · Director · 10% Owner | Sell · F | 442,692 | $236.93 | $104.89M | Neutral+8 | ||
4d ago Jun 24, 2026 | DICK'S SPORTING GOODS, INC. | STACK EDWARD W Executive Chairman · Director · 10% Owner | Buy · M | 958,466 | $11.31 | $10.84M | Neutral+8 | ||
4d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | SOUZA COLIN J VP & Chief Financial Officer | Buy · A | 810 | $0.00 | $0 | Neutral+5 | ||
4d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | SOUZA COLIN J VP & Chief Financial Officer | Buy · A | 1,630 | $0.00 | $0 | Neutral+5 | ||
4d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | SOUZA COLIN J VP & Chief Financial Officer | Buy · A | 2,990 | $0.00 | $0 | Neutral+5 | ||
4d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | Caravati Steven M President - Consumer Products | Buy · A | 100 | $0.00 | $0 | Neutral+5 | ||
4d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | Caravati Steven M President - Consumer Products | Buy · A | 210 | $0.00 | $0 | Neutral+5 | ||
4d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | Caravati Steven M President - Consumer Products | Buy · A | 1,600 | $0.00 | $0 | Neutral+5 | ||
4d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | Caravati Steven M President - Consumer Products | Buy · A | 2,880 | $0.00 | $0 | Neutral+5 | ||
4d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | Kennedy Patrick J. VP-General Counsel & Secy | Buy · A | 380 | $0.00 | $0 | Neutral+2 | ||
4d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | Kennedy Patrick J. VP-General Counsel & Secy | Buy · A | 760 | $0.00 | $0 | Neutral+2 | ||
4d ago Jun 25, 2026 | WORTHINGTON ENTERPRISES, INC. | Kennedy Patrick J. VP-General Counsel & Secy | Buy · A | 3,630 | $0.00 | $0 | Neutral+2 | ||
4d ago Jun 25, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Buy · M | 9,500 | $0.00 | $0 | Neutral+1 | 10b5-1Deriv | |
4d ago Jun 25, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 240 | $554.84 | $133.2K | Neutral+1 | 10b5-1 | |
4d ago Jun 25, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 800 | $553.97 | $443.2K | Neutral+1 | 10b5-1 | |
4d ago Jun 25, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 1,778 | $552.68 | $982.7K | Neutral+1 | 10b5-1 | |
4d ago Jun 25, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 1,814 | $551.61 | $1.00M | Neutral+1 | 10b5-1 | |
4d ago Jun 25, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 1,617 | $550.86 | $890.7K | Neutral+1 | 10b5-1 | |
4d ago Jun 25, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 762 | $549.55 | $418.8K | Neutral+1 | 10b5-1 | |
4d ago Jun 25, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 645 | $548.77 | $354.0K | Neutral+1 | 10b5-1 | |
4d ago Jun 25, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 441 | $547.87 | $241.6K | Neutral+1 | 10b5-1 | |
4d ago Jun 25, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 301 | $546.38 | $164.5K | Neutral+1 | 10b5-1 | |
4d ago Jun 25, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 418 | $545.08 | $227.8K | Neutral+1 | 10b5-1 | |
4d ago Jun 25, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Sell · S | 684 | $543.54 | $371.8K | Neutral+1 | 10b5-1 | |
4d ago Jun 25, 2026 | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO · Director | Buy · M | 9,500 | $135.42 | $1.29M | Neutral+1 | 10b5-1 | |
4d ago Jun 24, 2026 | WYNN RESORTS LTD | FERTITTA TILMAN J 10% Owner | Sell · S | 100,000 | $3.85 | $384.7K | Mild sell-25 | Deriv | |
4d ago Jun 24, 2026 | WYNN RESORTS LTD | FERTITTA TILMAN J 10% Owner | Sell · S | 100,000 | $4.07 | $406.6K | Mild sell-25 | Deriv | |
4d ago Jun 24, 2026 | WYNN RESORTS LTD | FERTITTA TILMAN J 10% Owner | Sell · S | 100,000 | $4.30 | $430.1K | Mild sell-25 | Deriv | |
4d ago Jun 25, 2026 | JOHN WILEY & SONS, INC. | Kowalski Jessica Patricia EVP and GM, Research | Buy · A | 20,000 | $0.00 | $0 | Neutral+2 | Deriv | |
4d ago Jun 25, 2026 | JOHN WILEY & SONS, INC. | Kowalski Jessica Patricia EVP and GM, Research | Buy · A | 15,660 | $0.00 | $0 | Neutral+2 | Deriv | |
4d ago Jun 25, 2026 | JOHN WILEY & SONS, INC. | Albright Craig Morrow EVP, Chief Financial Officer | Buy · A | 20,000 | $0.00 | $0 | Neutral+5 | Deriv | |
4d ago Jun 25, 2026 | JOHN WILEY & SONS, INC. | Albright Craig Morrow EVP, Chief Financial Officer | Buy · A | 12,752 | $0.00 | $0 | Neutral+5 | Deriv | |
4d ago Jun 25, 2026 | JOHN WILEY & SONS, INC. | Weber Andrew EVP, Technology and Operations | Buy · A | 8,680 | $0.00 | $0 | Neutral+2 | Deriv | |
4d ago Jun 25, 2026 | JOHN WILEY & SONS, INC. | Silver Deirdre P. EVP, General Counsel | Buy · A | 6,443 | $0.00 | $0 | Neutral+2 | Deriv | |
4d ago Jun 25, 2026 | JOHN WILEY & SONS, INC. | Caridi Christopher SVP, Chief Accounting Officer | Buy · A | 2,054 | $0.00 | $0 | Neutral+5 | Deriv | |
4d ago Jun 25, 2026 | JOHN WILEY & SONS, INC. | Monaco Kevin SVP, Treasurer & Tax | Buy · A | 1,705 | $0.00 | $0 | Neutral+2 | Deriv | |
4d ago Jun 25, 2026 | JOHN WILEY & SONS, INC. | Kissner Matthew President and CEO · Director | Buy · A | 40,268 | $0.00 | $0 | Neutral+6 | Deriv | |
4d ago Jun 25, 2026 | PTC THERAPEUTICS, INC. | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Buy · M | 100 | $0.00 | $0 | Neutral-3 | 10b5-1Deriv | |
4d ago Jun 25, 2026 | PTC THERAPEUTICS, INC. | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Buy · M | 19,859 | $0.00 | $0 | Neutral-3 | 10b5-1Deriv | |
4d ago Jun 25, 2026 | PTC THERAPEUTICS, INC. | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Buy · M | 1,001 | $0.00 | $0 | Neutral-3 | 10b5-1Deriv | |
4d ago Jun 24, 2026 | PTC THERAPEUTICS, INC. | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Buy · M | 4,922 | $0.00 | $0 | Neutral-3 | 10b5-1Deriv | |
4d ago Jun 24, 2026 | PTC THERAPEUTICS, INC. | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Buy · M | 401 | $0.00 | $0 | Neutral-3 | 10b5-1Deriv |
